Search - tctmd.com

Displaying 241 - 260 of 285

Sort: Relevancy | Date

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

News Daily News

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Michael O'Riordan

June 06, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Daily News

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Michael O'Riordan

June 06, 2016

Presentation

Stent Thrombosis With DES and Absorb Bioresorbable Scaffold

Presenter: S.H. Kang

June 03, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

Presentation ACC 2016

Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial

Presenter: Gregg W. Stone

April 03, 2016

News Daily News

AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis

Michael O'Riordan

March 30, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

Absorb BVS：两项新研究解决了安全性、有效性和支架血栓问题

Michael O'Riordan

March 30, 2016

Presentation

1-Year Outcomes With Absorb BVS: Patient-Level, Pooled Meta-Analysis

Presenter: Gregg Stone

March 29, 2016

News Daily News

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Michael O'Riordan

February 23, 2016

News Daily News

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Michael O'Riordan

February 23, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Industry News

Xeltis Completed Second Feasibility Clinical Trial on Bioabsorbable Cardiovascular Device Technology

November 09, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Advertisement

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Stent Thrombosis With DES and Absorb Bioresorbable Scaffold

TCTMD’s Top 10 Most Popular Stories for May 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial

AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Absorb BVS：两项新研究解决了安全性、有效性和支架血栓问题

1-Year Outcomes With Absorb BVS: Patient-Level, Pooled Meta-Analysis

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

TCTMD’s Top 10 Most Popular Stories for January 2016

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Xeltis Completed Second Feasibility Clinical Trial on Bioabsorbable Cardiovascular Device Technology

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content